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Abstract 
Background: Bioactive soluble carbon nanostructures, such as the C60 fullerene can bond with up to six electrons, 
thus serving by a powerful scavenger of reactive oxygen species similarly to many natural antioxidants, widely used 
to decrease the muscle fatigue effects. The aim of the study is to define action of the pristine C60 fullerene aqueous 
colloid solution (C60FAS), on the post-fatigue recovering of m. triceps surae in anaesthetized rats.
Results: During fatigue development, we observed decrease in the muscle effort level before C60FAS administration. 
After the application of C60FAS, a slower effort decrease, followed by the prolonged retention of a certain level, was 
recorded. An analysis of the metabolic process changes accompanying muscle fatigue showed an increase in the 
oxidative stress markers H2O2 (hydrogen peroxide) and TBARS (thiobarbituric acid reactive substances) in relation to 
the intact muscles. After C60FAS administration, the TBARS content and H2O2 level were decreased. The endogenous 
antioxidant system demonstrated a similar effect because the GSH (reduced glutathione) in the muscles and the CAT 
(catalase) enzyme activity were increased during fatigue.
Conclusions: C60FAS leads to reduction in the recovery time of the muscle contraction force and to increase in the 
time of active muscle functioning before appearance of steady fatigue effects. Therefore, it is possible that C60FAS 
affects the prooxidant-antioxidant muscle tissue homeostasis, subsequently increasing muscle endurance.
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Background
Skeletal muscle fatigue is the defence mechanism against 
overload and leads to the development of painful muscle 
sensitivity [1–3]. Muscle fatigue develops after physi-
cal activities of varying intensities and often leads to 
acute pain, which can then lead to various chronic dis-
ease states [4, 5]. Muscle fatigue is a result of the prod-
ucts of incomplete oxygen oxidation, such as reactive 
oxygen species (ROS), including peroxides, free radicals, 
and oxygen ions [6]. During the course of lipid peroxi-
dation, unsaturated fatty acids are formed from various 
fatty acid derivatives and metabolites, such as malondi-
aldehyde and hydroperoxide fatty acid [7]. The excessive 
accumulation of ROS (oxidative stress) can lead to signif-
icant functional changes due to damage to different cell 
components [8]. An example is the lipid peroxidation of 
biological membranes, which promotes the disruption of 
their structure and increases their permeability [9]. Cell 
protection against such damage is provided by the anti-
oxidant system. Mach et  al. [10] used pycnogenol as an 
antioxidant, and its use is accompanied by an increase 
in the levels of both oxidized and reduced NAD+ in the 
serum, as well as increased muscle strength. In studies 
of muscle fatigue, endogenous antioxidants, such as an 
N-acetylcysteine [11] and β-alanine [12], are widely used 
and speed up the muscle recovery process after fatigue. 
Open Access
Journal of Nanobiotechnology
*Correspondence:  maznychenko@biph.kiev.ua 
2 Department of Movement Physiology, Bogomoletz Institute 
of Physiology, Bogomoletz Str. 4, Kiev 01024, Ukraine
Full list of author information is available at the end of the article
Page 2 of 12Prylutskyy et al. J Nanobiotechnol  (2017) 15:8 
In this context, bioactive soluble carbon nanostruc-
tures, such as the pristine C60 fullerenes, may be con-
sidered potential antioxidants [13]. C60 fullerene easily 
bonds with up to six electrons, can serve as a powerful 
scavenger of ROS [13–15], and is superior to the major-
ity of natural antioxidants, including vitamins C and E 
and carotenoids, in regard to its antioxidant capacity. 
As a result, it prevents oxidative stress dissemination in 
thymocytes [16] and shows a protective effect following 
the ischemia–reperfusion injury of skeletal muscle [17]. 
Additionally, water-soluble pristine C60 fullerenes can 
penetrate through the plasma membrane of cells [18, 19]. 
Therefore, the use of C60 fullerenes may have a powerful 
antioxidant effect on the contractile apparatus of striated 
muscle, thereby facilitating its functional recovery after 
experimentally induced fatigue.
The aim of this study was to investigate the effect of 
water-soluble pristine C60 fullerenes on the recovery 
dynamics of the contractile properties of rat m. triceps 
surae (TS) after the development muscle fatigue under 
conditions of long-term activation.
Methods
Material preparation and characterization
A highly stable reproducible pristine C60 fullerene aque-
ous colloid solution (C60FAS) at a concentration of 
0.15  mg/ml was prepared according to a previous pro-
tocol [20, 21]. Briefly, for the preparation of C60FAS 
we used a saturated solution of pure C60 fullerene 
(purity  >99.99%) in toluene with a C60 molecule con-
centration corresponding to maximum solubility near 
2.9  mg/ml, and the same amount of distilled water in 
an open beaker. The two phases formed were treated in 
ultrasonic bath. The procedure was continued until the 
toluene had completely evaporated and the water phase 
became yellow colored. Filtration of the aqueous solu-
tion allowed to separate the product from undissolved 
C60 fullerenes. The pore size of the filter during the filtra-
tion of the aqueous solution was smaller than 2 µm (Typ 
Whatmann 602 h1/2). The purity of prepared C60FAS 
(i.e., the presence/absence of any residual impurities, for 
example carbon black, toluene phase) was determined by 
HPLC and GC/MS analysis. The maximal concentration 
of C60 fullerenes in water 0.15  mg/ml was obtained by 
this method.
The state of C60 fullerenes in aqueous solution was 
monitored using atomic force microscopy (AFM). Under 
AFM analysis, the sample was deposited onto a cleaved 
mica substrate (V-1 Grade, SPI Supplies) by precipitation 
from an aqueous solution droplet. Sample visualization 
was performed in semi-contact (tapping) mode (Fig. 1a, 
b). AFM measurements were performed after the com-
plete evaporation of the solvent.
Small-angle neutron scattering (SANS) measurements 
(Fig.  1c) were carried out at the YuMO small-angle dif-
fractometer at the IBR-2 pulsed reactor (JINR, Dubna, 
Russia) in the time-of-flight mode with the two-detector 
setup [22]. Treatment of the raw data was performed by 
the SAS program [23].
Procedure and experimental groups
Male Wistar rats, weighing 280–350 g, were used in the 
study. The use of the animals was approved by the Ethics 
Committee of the Institute and performed in accordance 
with the European Communities Council Directive of 24 
November 1986 (86/609/EEC).
The animals were divided into 4 groups. In the experi-
ments, the m. triceps surae fatigue was induced by elec-
trical stimulation of n. tibialis. Saline solution (group 1, 
n = 6) or C60FAS (F-injection) 0.1–0.15 mg/kg (group 2, 
n = 6) was administered into the left TS after the devel-
opment of fatigue. Then, fatigue of the right TS was 
induced. The data obtained from the ipsilateral (left) 
side were considered to be the control values vs. those 
obtained from the contralateral side. The dose range of 
0.1–0.15  mg/kg C60FAS does not present any acute or 
subacute toxicity in rats [13]. The rats of group 3 (n = 6; 
animals with fatigue of both TS without any injections) 
and group 4 (n =  6; intact animals) were used only for 
biochemical studies. After the experiment, the TS of 
all animals in all groups were removed for biochemical 
analysis.
It is important to note that a dose of 0.1–0.15  mg/kg 
C60FAS applied in our experiments does not present any 
acute or subacute toxicity in animals: it was significantly 
lower than the maximum tolerated dose of C60 fullerene, 
which was found to be 5 g/kg both for oral or intraperito-
neal administration to rats [13]. No toxic effects or death 
have been fixed under the action of C60 fullerenes after 
their oral administration to rats in total dosage of 2 g/kg 
for 14 days [24]. Finally, it was shown [13] that water-sol-
uble C60 fullerenes administered intraperitoneally to rats 
(0.5 mg/kg) were subjected to clearance from the organ-
ism within 2–4 days.
The animals in groups 1 and 2 were anaesthetized 
with ketamine (100 mg/kg “Pfizer”, USA) combined with 
xylazine (10  mg/kg, “Interchemie”, Holland), tracheos-
tomized and artificially ventilated (out of necessity). The 
left and right TS muscles were separated from the sur-
rounding tissue, and their tendons were detached at the 
distal insertions. The n. tibialis was separated from the 
tissue and cut proximally, and all branches of the nerve, 
except those innervating the TS, were cut. This nerve was 
mounted on a bipolar platinum wire electrode for elec-
trical stimulation. The hindlimb muscles and nerves were 
covered with paraffin oil in a pool formed from skin flaps. 
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The TS muscle was connected via the Achilles tendon to 
the servo-control muscle puller. The muscle tension was 
measured by semi-conductor strain gauge resistors glued 
on a stiff steel beam mounted on the moving part of a lin-
ear motor.
To induce muscle fatigue, 1–3 (30 min duration) series 
intermittent high-frequency electrical stimulation was 
used (Fig. 2a), separated by rest intervals of 10–20 min. 
Each series consisted of trains of 0.2-ms rectangular 
pulses at a rate of 40/s at 12.4  s duration and separated 
by 5 s intervals of rest (Fig. 2b). The stimulus current was 
set to 1.3–1.4 times the motor threshold. Note, if mus-
cle fatigue developed in less than 30  min, stimulation 
was interrupted (it was predicted that fatigue develop-
ment occurred when there was a muscle force decrease 
of more than 50% of the initial data). After the end of the 
12.4-s-stimulation, the muscle was stretched, and the 
change in length had a bell-shaped form (one period of 
4  Hz sinusoidal signal with corresponding phase lock-
ing) of 3.5 mm amplitude and 2 s duration (Fig. 2b; bot-
tom row). The muscle reaction to the stretches appeared 
as a tension increase after continuous stimulation. These 
stretches were applied before the post-stimulation 
twitches to remove, or at least diminish, the after-effects 
remaining from the continuous stimulation [1]. The sig-
nals (stimulus pulses, muscle tension and other) were 
sampled via DAC-ADC device (CED Power 1401).
Biochemical experiment
For biochemical analysis, the excised m. triceps surae 
(soleus and gastrocnemius) were rapidly dissected, free of 
fat and tendon, divided into several portions and stored 
in liquid N2. For reduced glutathione (GSH) analysis, tis-
sue samples were transferred into a medium containing 
1  N perchloric acid (1:10 w/v) and homogenized with 
a motor-driven Potter–Elvehjem glass homogenizer. 
The resultant homogenate was centrifuged at 10,000g 
for 10  min (4  °C). The GSH content was spectropho-
tometrically measured [25]. For the enzyme activity 
assays and H2O2 and lipid peroxidation assays, the mus-




Fig. 1 AFM images (tapping mode) of C60 fullerene particles on the 
mica surface, which were precipitated from C60FAS with an initial 
concentration of 0.15 mg/ml (a, b). Arrows indicate the height of 
the individual particles. Experimental SANS curve (points) for C60FAS 
(0.15 mg/ml). Solid lines correspond to the model curve obtained by 
the IFT procedure. Insert: the pair distance distribution function as a 
result of the IFT procedure for scattering from C60 fullerene nanoparti-
cles present in the C60FAS (c)
◂
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phosphate buffer with 2 mM EDTA (pH 7.4) at 4 °C (1:9 
w/v). Homogenates were then centrifuged for 15 min at 
15,000g (4  °C), and the post mitochondrial supernatant 
was stored at −70 °C.
Oxidative damage in the tissue was measured using the 
thiobarbituric acid reactive substances (TBARS) assay. 
TBARS were isolated by boiling tissue homogenates for 
15  min at 100  °C with thiobarbituric acid reagent (0.5% 
2-thiobarbituric acid/10% trichloroacetic acid/0.63  M/
dm3 hydrochloric acid) and measuring the absorbance at 
532 nm. The results are expressed as nM TBARS/mg pro-
tein, using ɛ = 1.56 × 105 dm3/M1/cm1 [26].
The H2O2 concentration in the tissue homogenates was 
measured using the FOX method, which is based on the 
peroxide-mediated oxidation of Fe2+, followed by the 
reaction of Fe3+ with xylenol orange (o-cresolsulphoneph-
thalein 3′,3″-bis[methylimino] diacetic acid, sodium salt). 
This method is extremely sensitive and is used to meas-
ure low levels of water-soluble hydroperoxide present in 
the aqueous phase. To determine the H2O2 concentra-
tion, 500 μl of the incubation medium was added to 500 μl 
of assay reagent (500  μM ammonium ferrous sulphate, 
50 mM H2SO4, 200 μM xylenol orange, and 200 mM sorb-
itol). The absorbance of the Fe3+-xylenol orange complex 
(A560) was detected after 45 min. Standard curves of H2O2 
were obtained for each independent experiment by add-
ing variable amounts of H2O2 to 500 μl of basal medium 
mixed with 500 μl of assay reagent. Data were normalized 
and expressed as μM H2O2 per mg protein [27].
Catalase activity was measured by the decomposition 
of hydrogen peroxide, determined by a decrease in the 
absorbance at 240 nm [28].
GSH was determined using Ellman’s reagent. One mil-
lilitre of supernatant was treated with 0.5 ml of Ellman’s 
reagent (5.5′-dithio-bis-nitrobenzoic acid in abs. ethanol) 
and 0.4 M Tris HCl buffer with 2 mM EDTA, pH 8.9. The 
absorbance was read at 412 nm in a spectrophotometer 
[25].
The protein concentration was estimated using the 
method of Bradford with bovine serum albumin as a 
standard. All chemicals were purchased from Sigma, 
Fluka and Merck and were of the highest purity.
Data analysis
In the electrophysiological part of the study, each stimula-
tion series (30 min) was divided into three equal portions 
(Fig. 2a), which were averaged (maximum 33 stimulation 
in one portion). The average value of the first portion was 
set to 100%, and the other series were normalized in rela-
tion to this (for each hindlimb). The peak amplitudes of 
the front (P1) and rear of the front (P2) (maxima ampli-
tudes at the site, duration of 1  s, Fig.  2b) of the muscle 
strength of each single series (12.4 s) were identified and 
the difference between P1 and P2 (ΔP) was calculated. 
This difference determines the dynamic component of 
the muscle force decrease in a short period of continuous 
stimulation. Mean values (mean  ±  SD) of the TS mus-
cle strength before and after F-injection were compared 
using a two-way statistical analysis of variance (ANOVA). 
The factors of variation included two conditions, time and 
the effects of the C60FAS. A Bonferroni post hoc analysis 
was used to determine the differences between groups. 
The level of significance was set at p < 0.001.
Biochemical data are expressed as the means ± SEM 
for each group. The differences among experimental 
groups were detected by one-way ANOVA followed by 




















Fig. 2 Strength of the contralateral (right) m. triceps surae (TS) contraction during the 2nd series of 30-min intermittent stimulations of the n. tibialis 
at 42 min after C60FAS administration into the left TS (a). The superposition of individual tetanic contractions 2 and 28 are presented at the higher 
time scale (b). P muscle force, st stimulation mark, L muscle length (mm); S1, S2 and S3 equal parts of the stimulus series, used for the quantitative 
analysis of data; P1 and P2 sites at the beginning and at the end of tetanic contraction
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Results
Analysis of AFM and SANS data
Because the C60 fullerene particle size directly correlates 
with their biodistribution and toxicity [29, 30], the AFM 
and SANS studies were performed.
The AFM images (Fig. 1a, b) clearly demonstrate ran-
domly arranged, individual C60 fullerenes (0.7  nm in 
diameter) and their bulk clusters with a height of 1.5–
200 nm. At the same time, some individual C60 fullerene 
aggregates with a height of >200 nm are also seen in the 
AFM image (Fig. 1b). The results obtained are consistent 
with the theoretical calculations and experimental meas-
urements [20, 21, 31, 32] and demonstrate the polydis-
persity of the C60FAS used in our study.
Experimental SANS curve for C60FAS is shown in 
Fig. 1c. The scattering curve of C60FAS is well described 
by the form-factor of polydisperse spherical particles. 
The mean radius of gyration of the particle cross section, 
Rg, and pair distance distribution function, P(r), were 
found by using indirect Fourier transformation (IFT) 
approach [33]. We can calculate the radius of particles, 
R, present in the C60FAS according to well-known equa-
tion Rg2 = 0.6R2 assuming of homogeneous and spherical 
of C60 fullerene clusters. This conclusion follows from 
previous experimental data [20, 21] and the estimates 
of the average cluster density according to the contrast-
variation experiments [31, 32, 34]. The data given by this 
procedure indicate that C60FAS consists of C60 fullerene 
sphere-like nanoparticles with an average size of ~56 nm 
that is in a good agreement with above AFM data.
It is known [35, 36] that the permeability and cyto-
chemical behavior of nanoparticles strongly depend on 
their size and, correspondingly, mass (number) distri-
bution. In this regard, our previous studies [16, 18, 19, 
29] clear demonstrate that the used C60 fullerene nano-
particles can effectively penetrate through the plasma 
membrane of cells by passive diffusion or endocytosis 
(depending on the size) and do not exhibit cytotoxic 
effects.
Electrophysiological experiments
Changes in the TS force reaction under fatigue conditions 
due to prolonged high frequency stimulation (30  min, 
40/s) of the n. tibialis for animal groups 1 (before and 
after administration of saline solution) and 2 (before the 
application of C60FAS) did not significantly differ. The 
analysis was performed by determining the force level 
at the beginning (P1) and end (P2) of single tetanic con-
tractions and the difference between these values (ΔP), 
which determines the dynamic component of the force 
decrease during a short period of continuous stimulation 
(Fig.  2b). The muscle was considered tired if the ampli-
tude of the single tetanic contractions decreased by more 
than 50% relative to the initial level. When muscle fatigue 
was reached, the stimulation was stopped and followed 
by a 10–20 min rest period. Therefore, in the case of one 
animal, as a result of muscle fatigue stimulation of the 
left TS, a 50% fatigue level was reached in approximately 
12 min; during the next 4 min of stimulation, it contin-
ued to decrease [Fig. 3a (IL), b(IL)]. After 10 min of rest, 
a single tetanic contraction force was slightly restored, 
but it did not reach the initial muscle activity level and 
continued to decrease rapidly [Fig.  3a (IIL), b(IIL)]. In 
this case, there was also a simultaneous decrease in the 
dynamic component of the force drop ΔP. Note that the 
dynamic component was the most highly expressed at 
the beginning of the first experimental series and that 
the P1 amplitude was higher relative to the P2 amplitude 
[Fig.  3b (IIL)]. After tetanic contractions for 1.5–2  min, 
difference between amplitudes P1 and P2 was reduced 
to zero, with moderate variations both in one and the 
opposite direction over the additional fatigue stimulation 
period. Simultaneously with the decrease in ΔP values, 
there was a constant decrease in the developed force. In 
the following stimulation series, after a period of rest, the 
initial amplitude of the dynamic component was usually 
decreased [Fig. 3b (IIL, IIIL)].
When a predetermined level of muscle fatigue was 
reached, C60FAS (0.1–0.15  mg/kg) was injected intra-









)]. At the same time, 
the dynamic changes in the muscle strength level in 
response to stimulation reflected the further develop-
ment of fatigue, and the single contraction forces were 
reduced rapidly [Fig.  3b(IF
L
)]. However, F-injection led 
to the gradual recovery of the isometric force levels (at 





appearance of negative ΔP values (P2 amplitude increase 
compared to P1 amplitude) indicated the beginning of the 
recovery [Fig. 3b (IIF
L
), 10th min]. In this series of stimula-
tions, the level of the muscle contraction force was recov-
ered to that developed during the initial stages of fatigue 
stimulation.
Power reaction of the right TS was significantly differ-
ent from the left TS. Notably, the TS of the right limb was 
not previously fatigued before the F-injection (Fig.  3c, 
d). At 52 min after drug administration, a certain force 
muscle decrease was observed. In this case, the P1 ampli-
tude was higher than the P2 amplitude, as indicated by 





at 6  min after the beginning of fatigue stimulation, the 
force developed by the muscle appeared at a certain sta-
tionary level, which was held during the experimental 
series. The difference between the P1 and P2 amplitudes 
disappeared (value of ΔP decreased to zero), which may 
indicate a constant force level at the time of loading. It 





Fig. 3 Strength of the ipsi- and contralateral m. triceps surae (TS) contraction induced by electrical fatigue stimulation before and after C60FAS injec-
tion into the left TS: a, c time protocol registrations of the left and right TS contraction, respectively (triangles indicate the moment the of the C60FAS 
injection); b, d amplitude values of the muscle force (P1) at the beginning of single tetanic contractions (squares) and ΔP (the difference between 
the force values at the beginning and at the end of muscle contraction; triangles). The rapid development of fatigue (a) (decrease in the muscle 
strength of more than 50%) led to shortening of the stimulation time (I–III). Designations for I–IV (a) and I–III at (c) correspond to recordings on (b) 
and (d), respectively. Indices: L, R left and right TS; F registration of muscle force after the administration of C60FAS into the left TS
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is significant that the muscle maintained the developed 










)]. For this muscle, the total time of the decrease of 
the isometric force contraction by 50% was 120 min after 
drug administration. For comparison, the control dura-
tion of the fatigue occurrence period was 42 min.
In Fig.  4a, b, a comparison of the force level changes 
developed by the left TS before (IL) and after (IFL) F-injec-
tion in two different experiments is presented. The sta-
tistical analysis showed a significant (p  <  0.001) force 
decrease during the series of fatigue stimulation before 
C60FAS administration [Fig. 4a (IL), b(IL)]. After F-injec-
tion, a recovery of the muscle force for the first animal 
[Fig. 4a (IF
L
)] and its holding for the second animal [Fig. 4b 
(IF
L
)] was observed. At the end of the experimental 
series, the recovery of the active muscle force response 
was significant compared to that at the beginning and 
nearly reached the control values. The analysis showed 
a significant effect for the factors: drug administration 
(D) and time (T) after administration and their interac-
tion. The corresponding results of this analysis were as 
follows: F(D)  =  2904.47, p(D)  <  0.001, F(T)  =  42.420, 
p(T)  <  0.001, F(DxT)  =  1350.58, p(DxT)  <  0.001 (first 
animal) and F(D) = 122.80, p(D) < 0.001, F(T) = 1058.29, 
p(T) < 0.001, p(DxT) = 1287.35, p(DxT) < 0.001 (second 
animal). The data obtained in all experiments (Fig. 4c–h) 
indicate that the decrease in the developed force after 
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Fig. 4 Averaged characteristics (mean ± SD) of normalised (to average values S1) values of the muscle strength during different parts of the fatigue 
stimulation (S1, S2, and S3; Fig. 2) before and after (white and grey bars, respectively) C60FAS administration into the left m. triceps surae (TS): a, b 
the results of two fatigue tests before and after C60FAS administration into the left TS; c–h the results of six fatigue tests of the left TS (open bars) 
before C60FAS administration, and right TS (grey bars) at 52 min after C60FAS administration into the left TS. Asterisks significant differences (p < 0.001) 
between the muscle strength during time intervals S1 and S3 in one or more series of the stimulation. I, II successive series of fatigue stimulations 
(normalisation performed by S1 in series I). Indices: L, R left and right TS; F registration of muscle force after the administration of C60FAS into the left 
TS. Triangle marks the moment of C60FAS injection
Page 8 of 12Prylutskyy et al. J Nanobiotechnol  (2017) 15:8 
slower than in controls. The maximum significant reduc-
tion of the muscle force developed during the entire 
period of fatigue stimulation was 44% after drug admin-
istration, whereas in the control this was 85%. For all 
experimental animals, similar dynamics of the force level 
decrease in the control and its more gradual decrease 
after F-injection were observed.
Biochemical experiments
During long-term stimulation of the muscle, meta-
bolic processes change and are a main factor of muscle 
fatigue. As a result of the fatigue test, the accumulation 
of lipid peroxidation secondary products and changes 
in the levels of antioxidants in the tissue of the fatigued 
muscle were determined. The data clearly demonstrate 
the increased level of peroxidation and oxidative stress 
marker TBARS and H2O2 after fatigue stimulation 
(Fig. 5a, b). This increase was significant in relation to the 
intact muscle (‘norm’) and was 23% (p < 0.05) for TBARS 
and 38% (p  <  0.05) for H2O2. After C60FAS administra-
tion into the left TS, the TBARS concentration was sig-
nificantly reduced compared to fatigue as follows: 29% 
(p < 0.05) for the left TS and 12% (p < 0.05) for the right 
one. The H2O2 level decreases in comparison to the 
‘fatigue’ group (by 6% for the left TS and 7% for the right 
one), although the H2O2 level remained higher in relation 
to the intact group (p < 0.05). In turn, in response to such 
changes in the working muscle, an activation of endog-
enous antioxidants occurred. During fatigue stimulation, 


































































































































Fig. 5 Indicators of the prooxidant-antioxidant balance in the m. triceps surae (TS) of rats. The concentration of thiobarbituric acid reactive 
substances (TBARS) (a), hydrogen peroxide (H2O2) (b), glutathione (GSH) (c) and catalase (CAT) (d) are in intact animal muscles (norm), with the 
left fatigued TS (fatigue) and after C60FAS administration ipsi- and contralaterally [C60FAS (left) and C60FAS (right), correspondingly]. Values are the 
mean ± SEM, n = 6. *p < 0.05 vs. “norm”; #p < 0.05 vs. “fatigue”
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than two-fold (p  <  0.05) and the activity of the antiper-
oxide enzyme CAT also increased. After C60FAS admin-
istration, the GSH and CAT activities were significantly 
decreased compared to the group ‘fatigue’ by 41.8 and 
15.4% for GSH and 53 and 43% for CAT (p < 0.05) for the 
left and right TS, respectively (Fig. 5c, d).
Discussion
In this study, we investigated changes in the contraction 
force of the rat m. triceps surae under fatigue develop-
ment before and after C60FAS administration. We did not 
use a level of stimulation above 40 Hz, and the rest period 
between the experimental series was 15–20 min [2]. This 
experimental approach allows us to analyse the nature of 
the muscle contraction force parameter changes under 
fatigue stimulation before C60FAS application (into the 
left TS) and directly after F-injection. A marked decrease 
in the muscle effort level before C60FAS administra-
tion (control) was observe in the all experiments both IL 
and IIL stimulation series (Fig. 4a–h). It was the result of 
modified stimulation pattern action, which was due to 
the influence of the central and peripheral mechanisms 
of the development of skeletal muscle fatigue [2]. After 
intramuscular injection of the C60FAS partial ipsilateral 
TS muscle recovery was registered in two rats. However, 
the main finding was observed after the application of 
C60FAS. Not significant a slower effort decrease, followed 
by the prolonged retention of a certain level was recorded 
contralaterally in all animals. Decrease in the muscle con-
traction force was developed more slowly after C60FAS 
administration compared to the control. It indicates 
a deceleration of the fatigue process, and the strength 
restraint at the constant level for a long time (120 min) 
indicates an increase in the muscle endurance during 
such conditions. The data obtained in this study indicate 
that after drug injection, the time for the TS force maxi-
mal level decrease to 44% was 120 min. At the same time 
in the control, the force level of this muscle during the 
same period decreased to 85%. We suppose, it was caused 
by antioxidant effects C60FAS on the fatiguing muscle. 
The duration of the muscle recovery and its rest peri-
ods are also important factors for maintaining efficiency 
and the normal physiological state of the muscle during 
dynamic work execution [12]. The dynamic component 
of the single tetanic contraction is likely a reflection of 
the interaction of the efficiency of the initial increase of 
the fast motor unit contractile properties and processes 
of the fatigue strength reduction [37]. Thus, recovery of 
muscle strength after F-injection both for the preliminary 
tired and at fresh muscles indicate, that water-soluble 
pristine C60 fullerenes can penetrate through the plasma 
membrane of cells [18, 19] and render of powerful anti-
oxidant effect on the contractile apparatus of striated 
muscle, thereby facilitating its functional recovery after 
experimentally induced fatigue.
Under a moderate external load on the muscle, metab-
olism occurs aerobically. In the actively contracted mus-
cle, metabolism significantly increases, resulting in the 
accumulation of secondary oxidation products in muscle 
fibres, which leads to fatigue development [38]. These 
metabolic processes are a source of oxygen free radicals 
and contribute to the intensification of lipid peroxida-
tion processes [39–41]. The presence of such metabo-
lism products prevents the adequate implementation of 
muscle work and increases the duration of the recovery 
period. Strenuous exercise and endurance training cause 
oxidative stress in skeletal muscle and can therefore alter 
the prooxidant-antioxidant balance [42, 43]. Despite 
extensive research over the years, the relationship 
between free radical generation, antioxidant enzymes 
and exercise in skeletal muscle remains controversial 
[44, 45]. These discrepancies may be related to differ-
ences in exercise mode, intensity, duration of the train-
ing program, and muscle fibre type. Skeletal muscles are 
highly heterogeneous. Each muscle fibre type has distinct 
metabolic characteristics and oxidative potential as well 
as antioxidant defence capacity [41]. In our study, as a 
result of fatigue stimulation in working muscle, there was 
a significant increase in the secondary products of lipid 
peroxidation and H2O2 compared to the intact (unstim-
ulated muscle) muscle (Fig.  5). During intense (physical 
activity) contraction, the flow of oxygen through muscle 
cells is greatly increased. High levels of oxygen uptake 
(up to 100-fold) can lead to excessive ROS generation and 
are implicated in fatigue, muscle soreness, and myofibril 
disruption [45]. Moreover, another potential mechanism 
involved in the oxidative stress response to high-intensity 
exercise is the redistribution of blood flow, such as ele-
vated blood flow in the heart, lung, and red slow-twitch 
muscle fibres, leading to increased mitochondrial respi-
ration, which results in an increase in the production of 
ROS. We found that long-term electrical stimulation of 
the muscle induced a significant increase in TBARS and 
H2O2 content that led to an increase of CAT activity and 
GSH content in both fast- and slow-twitch muscle fibres. 
In this case, after C60FAS administration, the oxygen 
metabolite concentration was significantly lower. This 
confirms the previous data regarding the protective effect 
of C60FAS on the immune and antioxidant systems of the 
body in various pathologies [15, 46]. The mechanisms of 
effects of this drug can positively influence the processes 
of endurance and recovery of the active muscles, inacti-
vating the products of its metabolism.
Increased amounts of GSH in the stimulated mus-
cle (without drug administration and after its applica-
tion) are evidence of the compensatory activation of the 
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endogenous antioxidant systems on the irritant action 
of sufficient strength (Fig. 5). Many studies showed that 
during intense stress, there is a significant decrease of 
reduced GSH and an increased concentration of its oxi-
dative form in the myocardium and m. soleus [47, 48]. 
Simultaneously, contradictory data were obtained in the 
experiments studying endurance [47, 49]. It was found 
that under physical activity, the amount of reduced GSH 
in the m. gastrocnemius and DVL increase. It is likely that 
in m. soleus, a muscle with a high content of myoglobin, 
all metabolic and biochemical processes occur under aer-
obic conditions, which use a large number of mitochon-
drial enzymes, and the accumulation of oxidized GSSG 
does not have time to reduce [50]. At the same time, 
the above mentioned processes in the m. gastrocnemius 
occur anaerobically, in contrast to the m. soleus. This 
causes a slow oxidation process and increases the amount 
of reduced GSH [51, 52]. Under fatigue, after C60FAS 
administration, the GSH content was somewhat reduced 
compared to the “fatigue” state, indicating a reduction in 
oxidative stress and a normalization of the pro- and anti-
oxidant balance in rat muscle tissue (Fig. 5).
An increase of H2O2 during exertion leads to an 
increase in CAT enzyme activity that has a protective 
antioxidant function by catalysing the decomposition of 
hydrogen peroxide to water and oxygen. These results are 
confirmed by previously obtained data from acute experi-
ments on rats with DVL stimulation [47, 52]. An increase 
of the enzyme activity in response to exercise was also 
shown in humans [53]. Moreover, some studies indicate 
an absence of any changes in CAT concentration in the 
muscles during physical activity [44, 54, 55]. In fact, sev-
eral reports demonstrated decreases in catalase activity 
in both oxidative and mixed fibre limb muscles [56, 57]. 
In our study, after C60FAS administration under fatigue 
development, the CAT activity was significantly reduced 
compared to pure fatigue and remained at the control 
level. It is hypothesized that C60FAS influence the con-
tent and activity of endogenous antioxidants and prevent 
the occurrence of fatigue in actively contracting muscle, 
thereby contributing to maintenance of its normal physi-
ological state.
Free radical processes increasing is the main patho-
genic factor during skeletal muscles fatigue develop-
ment [58]. Under significant physical activity there is 
highly overproduction of free radicals in muscle tissue 
that intensifies the processes of lipid peroxidation, cell 
membranes damage and antioxidant enzymes inactiva-
tion [59]. The active oxygen metabolites cause direct 
inhibition of respiratory chain mitochondrial enzymes 
and reducing the balance of ATP/ADF [59]. The above 
processes in the background of the lactate accumulation 
with subsequent development of acidosis and blockage of 
membrane Ca2+ channels lead to a pronounced energy 
deficit and a significant functional activity reduction of 
muscle tissue [60].
It is known that application of different nature exog-
enous antioxidants leads to a significant reduction of 
fatigue skeletal muscle during intense physical activ-
ity and increases the onset time of muscle fatigue under 
prolonged intense endurance exercise [10, 61, 62]. These 
data demonstrate the feasibility of using antioxidants to 
correct the level of oxidative stress in the muscle tissue 
under extreme influences on the body and its efficiency 
increasing. Since pristine C60 fullerenes, as previously 
shown in various models in vitro and in vivo [13, 15, 63], 
actively bind free radicals and display a powerful anti-
oxidant properties of direct action, we can assume that 
the application of water-soluble C60 fullerenes led to the 
prooxidant-antioxidant balance normalization in the 
muscle tissue of rats and helped improve the dynamic 
parameters of muscle contraction.
Conclusion
The use of C60FAS, even at a low therapeutic dose (0.1–
0.15 mg/kg) leads to a reduction in the recovery time of 
the muscle contraction force (after its complete exhaus-
tion state) on the one hand, and an increase in the time 
of the muscle active work (endurance) until fatigue devel-
opment on the other. This result illustrates the effect 
of C60FAS, along with other possible mechanisms, on 
prooxidant-antioxidant homeostasis in the muscle tissue 
of rats.
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